COVID-19 vaccines and kidney disease

Nat Rev Nephrol. 2021 Feb 8;1-3. doi: 10.1038/s41581-021-00406-6. Online ahead of print.

Abstract

Patients with kidney diseases should be prioritized for COVID-19 vaccination and the available data suggest that replication-defective viral-vectored vaccines and mRNA vaccines are safe to use. As vaccine responses are likely to be lower in patients with kidney diseases than in the general population, highly potent vaccines should be preferred.